References
- Baldessarini R J. Antipsychotic agents. Report of the American Psychiatric Association Commission on Psychiatric Therapeutics, B Karasu. American Psychiatric Association, Washington 1984; 119–170
- Rose J B. Tricyclic antidepressant toxicity. J Toxicol Clin Toxicol 1977; 11: 381–402
- Nicotra M B., Rivera M, Pool J L. Tricyclic antidepressant overdose: Clinical and pharmacological observations. J Toxicol Clin Toxicol 1981; 18: 599–613
- Therapeutic Class Profiles. Annual Data, 1988. Drug Abuse Warning Network. Statistical Series 1, No 8, National Institute on Drug Abuse, Rockville, MD 1989; 105–126
- Boehnest D G., Lovejoy F H., Jr. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after acute overdose of tricyclic antidepressant. N Engl J Med 1985; 313: 474–479
- Spiker D G., Weiss A N., Chang S S., Ruwitch J F., Biggs J T. Tricyclic antidepressant overdose: Clinical presentation and plasma levels. Clin Pharmacol Therap 1975; 18: 539–546
- Narasimhachari N, Saady J, Friedel R. Quantitative mapping of Imipramine by GC/MS. Biol Psychiat 1981; 16: 937–944
- ADx Operators' Guide. Diagnostics Division. Abbott Laboratories, North Chicago, ILUSA, 60064